Mojia Bioscience Funding: $95M Raised, Series B (2022)

Mojia Bioscience is based in Shanghai, China. It has raised $95M in total funding. Latest round: Series B. Backed by Temasek, LYZZ Capital, Sento Investment.

Mojia Bioscience funding overview

Mojia Bioscience is based in Shanghai, China. Mojia Bioscience has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2022. The round record for Mojia Bioscience runs through 2022; nothing later has been disclosed. Investors on record include Temasek, LYZZ Capital, Sento Investment, Bits x Bites, Asia Green Fund. 5 distinct backers are named across the disclosed rounds.

Mojia Bioscience at a glance

Total raised
$95M
Latest round
Series B
Latest round date
June 2022
Headquarters
Shanghai, China
Notable investors
Temasek, LYZZ Capital, Sento Investment, Bits x Bites, Asia Green Fund

Frequently asked about Mojia Bioscience funding

How much has Mojia Bioscience raised?
Mojia Bioscience has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Mojia Bioscience?
Temasek, LYZZ Capital, Sento Investment, Bits x Bites, Asia Green Fund are named among the investors backing Mojia Bioscience.
What was the latest Mojia Bioscience funding round?
The most recent disclosed round is a Series B, announced in June 2022.
Where is Mojia Bioscience based?
Mojia Bioscience is based in Shanghai, China.
When did Mojia Bioscience last raise?
The last disclosed Mojia Bioscience round closed in June 2022 at Series B.

We update the Mojia Bioscience record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Shanghai and their backers are listed below.

Companies related to Mojia Bioscience (36)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026